NEW YORK, Feb. 16 (GenomeWeb News) - The Center for Genetics and Genomics of Harvard Medical School and Partners HealthCare will use Affymetrix's GeneChip Human Mapping microarrays in a genotyping study of atherosclerosis, the two institutions said today.
In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.
